Diphyllobothrium infection

Revision as of 00:48, 9 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Jump to navigation Jump to search

WikiDoc Resources for Diphyllobothrium infection

Articles

Most recent articles on Diphyllobothrium infection

Most cited articles on Diphyllobothrium infection

Review articles on Diphyllobothrium infection

Articles on Diphyllobothrium infection in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Diphyllobothrium infection

Images of Diphyllobothrium infection

Photos of Diphyllobothrium infection

Podcasts & MP3s on Diphyllobothrium infection

Videos on Diphyllobothrium infection

Evidence Based Medicine

Cochrane Collaboration on Diphyllobothrium infection

Bandolier on Diphyllobothrium infection

TRIP on Diphyllobothrium infection

Clinical Trials

Ongoing Trials on Diphyllobothrium infection at Clinical Trials.gov

Trial results on Diphyllobothrium infection

Clinical Trials on Diphyllobothrium infection at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Diphyllobothrium infection

NICE Guidance on Diphyllobothrium infection

NHS PRODIGY Guidance

FDA on Diphyllobothrium infection

CDC on Diphyllobothrium infection

Books

Books on Diphyllobothrium infection

News

Diphyllobothrium infection in the news

Be alerted to news on Diphyllobothrium infection

News trends on Diphyllobothrium infection

Commentary

Blogs on Diphyllobothrium infection

Definitions

Definitions of Diphyllobothrium infection

Patient Resources / Community

Patient resources on Diphyllobothrium infection

Discussion groups on Diphyllobothrium infection

Patient Handouts on Diphyllobothrium infection

Directions to Hospitals Treating Diphyllobothrium infection

Risk calculators and risk factors for Diphyllobothrium infection

Healthcare Provider Resources

Symptoms of Diphyllobothrium infection

Causes & Risk Factors for Diphyllobothrium infection

Diagnostic studies for Diphyllobothrium infection

Treatment of Diphyllobothrium infection

Continuing Medical Education (CME)

CME Programs on Diphyllobothrium infection

International

Diphyllobothrium infection en Espanol

Diphyllobothrium infection en Francais

Business

Diphyllobothrium infection in the Marketplace

Patents on Diphyllobothrium infection

Experimental / Informatics

List of terms related to Diphyllobothrium infection


Overview

Also known as:

Tapeworm (broad or fish) infection

References

http://www.cdc.gov/ncidod/diseases/index_qz.htm#t

http://www.cdc.gov/ncidod/dpd/parasites/diphyllobothrium/default.htm

Epidemiology and Demographics

Diphyllobothriasis occurs in the Northern Hemisphere (Europe, newly independent states of the former Soviet Union [NIS], North America, Asia) and in Uganda and Chile. Freshwater fish infected with Diphyllobothrium sp. larva may be transported to and consumed in geographic areas where active transmission does not occur, resulting in human diphyllobothriasis. For example, cases of D. latum infection associated with consumption of imported fish have been reported in Brazil.

References

http://www.dpd.cdc.gov/dpdx/HTML/diphyllobothriasis.htm

Risk Factors

References

Pathophysiology & Etiology

The cestode Diphyllobothrium latum (the fish or broad tapeworm), the largest human tapeworm. Several other Diphyllobothrium species have been reported to infect humans, but less frequently; they include D. pacificum, D. cordatum, D. ursi, D. dendriticum, D. lanceolatum, D. dalliae, and D. yonagoensis.


Life cycle of Diphyllobothrium latum
Life cycle of Diphyllobothrium latum


Immature eggs are passed in feces 1 . Under appropriate conditions, the eggs mature (approximately 18 to 20 days) 2 and yield oncospheres which develop into a coracidia 3. After ingestion by a suitable freshwater crustacean (the copepod first intermediate host) the coracidia develop into procercoid larvae 4 . Following ingestion of the copepod by a suitable second intermediate host, typically minnows and other small freshwater fish, the procercoid larvae are released from the crustacean and migrate into the fish flesh where they develop into a plerocercoid larvae (sparganum) 5 . The plerocercoid larvae are the infective stage for humans. Because humans do not generally eat undercooked minnows and similar small freshwater fish, these do not represent an important source of infection. Nevertheless, these small second intermediate hosts can be eaten by larger predator species, e.g., trout, perch, walleyed pike 6 . In this case, the sparganum can migrate to the musculature of the larger predator fish and humans can acquire the disease by eating these later intermediate infected host fish raw or undercooked 7 . After ingestion of the infected fish, the plerocercoid develop into immature adults and then into mature adult tapeworms which will reside in the small intestine. The adults of D. latum attach to the intestinal mucosa by means of the two bilateral groves (bothria) of their scolex 8 . The adults can reach more than 10 m in length, with more than 3,000 proglottids. Immature eggs are discharged from the proglottids (up to 1,000,000 eggs per day per worm) 9 and are passed in the feces 10 . Eggs appear in the feces 5 to 6 weeks after infection. In addition to humans, many other mammals can also serve as definitive hosts for D. latum.

References

http://www.dpd.cdc.gov/dpdx/HTML/diphyllobothriasis.htm

Natural History

References

Diagnosis

Differential Diagnosis

References

History and Symptoms

Diphyllobothriasis can be a long-lasting infection (decades). Most infections are asymptomatic. Manifestations may include abdominal discomfort, diarrhea, vomiting, and weight loss. Vitamin B12 deficiency with pernicious anemia may occur. Massive infections may result in intestinal obstruction. Migration of proglottids can cause cholecystitis or cholangitis.

References

http://www.dpd.cdc.gov/dpdx/HTML/diphyllobothriasis.htm

Physical Examination

Appearance of the Patient

Vital Signs

Skin

Eyes

Ear Nose and Throat

Heart

Lungs

Abdomen

Extremities

Neurologic

Other

References

Laboratory Findings

Microscopic identification of eggs in the stool is the basis of specific diagnosis. Eggs are usually numerous and can be demonstrated without concentration techniques. Examination of proglottids passed in the stool is also of diagnostic value.

Diphyllobothrium latum egg
Diphyllobothrium latum egg

A, B: Eggs of Diphyllobothrium latum. These eggs are oval or ellipsoidal, with at one end an operculum that can be inconspicuous. At the opposite (abopercular) end is a small knob that can be barely discernible. The eggs are passed in the stool unembryonated. Size range: 58 to 76 µm by 40 to 51 µm.


Diphyllobothrium latum egg
Diphyllobothrium latum egg

C, D: Eggs of Diphyllobothrium latum. These eggs are oval or ellipsoidal, with at one end an operculum (arrows) that can be inconspicuous (D). At the opposite (abopercular) end is a small knob that can be barely discernible (C). The eggs are passed in the stool unembryonated. Size range: 58 to 76 µm by 40 to 51 µm. Figure C contributed by Georgia Division of Public Health.


Diphyllobothrium latum proglottids
Diphyllobothrium latum proglottids

E: Proglottids of Diphyllobothrium latum. These proglottids tend to be passed in strands of variable length in the stool. The proglottids tend to be broader than long. Image contributed by Georgia Division of Public Health.


Diphyllobothrium latum proglottids
Diphyllobothrium latum proglottids

F: Proglottids of Diphyllobothrium latum. The species characteristics are: the proglottid is broader than it is long; size 2 to 4 mm long by 10 to 12 mm wide; uterus coiled in rosette appearance; genital pore at the center of the proglottid.

Electrolyte and Biomarker Studies

References

http://www.dpd.cdc.gov/dpdx/HTML/diphyllobothriasis.htm

Electrocardiogram

References

Chest X Ray

References

MRI and CT

References

Other Imaging Findings

References

Other Diagnostic Studies

References

Risk Stratification and Prognosis

References

Treatment

Pharmacotherapy

Praziquantel is the drug of choice. Alternatively, Niclosamide can also be used to treat diphyllobothriasis. (Praziquantel is approved by the FDA, but considered investigational for this purpose).

Acute Pharmacotherapies

References

http://www.dpd.cdc.gov/dpdx/HTML/diphyllobothriasis.htm

Chronic Pharmacotherapies

References

Primary Prevention

References

Secondary Prevention

References

Cost-Effectiveness of Therapy

References

Future or Investigational Therapies

References

"The Way I Like To Do It ..." Tips and Tricks From Clinicians Around The World

Suggested Revisions to the Current Guidelines

References

<biblio>

</biblio>

Acknowledgements

The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.

List of contributors:

Suggested Reading and Key General References

Suggested Links and Web Resources

For Patients


Template:WH Template:WS